✦ LIBER ✦

Deficits in Striatal Dopamine D2 Receptors and Energy Metabolism Detected by in Vivo MicroPET Imaging in a Rat Model of Huntington's Disease

✍ Scribed by Dalia M. Araujo; Simon R. Cherry; Keith J. Tatsukawa; Tatsushi Toyokuni; Harley I. Kornblum

Book ID: 115607372
Publisher: Elsevier Science
Year: 2000
Tongue: English
Weight: 441 KB
Volume: 166
Category: Article
ISSN: 0014-4886
DOI: 10.1006/exnr.2000.7514

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Time course of changes in striatal dopam

Time course of changes in striatal dopamine transporters and D2 receptors with specific iodinated markers in a rat model of Parkinson's disease

✍ Sylvie Chalon; Patrick Emond; Sylvie Bodard; Marie-Paule Vilar; Cynthia Thiercel 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 539 KB

The time course of the loss in presynaptic dopamine transporters (DAT) and of the increase in postsynaptic dopamine D2 receptors (D2R) was studied in a rat model of Parkinson's disease. For this, in vitro autoradiographic experiments were performed in the striatum using (E)-N-(3-iodoprop-2-enyl)-2be

Exercise elevates dopamine D2 receptor i

Exercise elevates dopamine D2 receptor in a mouse model of Parkinson's disease: In vivo imaging with [18F]fallypride

✍ Marta G. Vučcković; Quanzheng Li; Beth Fisher; Angelo Nacca; Richard M. Leahy; J 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 291 KB

## Abstract The purpose of the current study was to examine changes in dopamine D2 receptor (DA‐D2R) expression within the basal ganglia of MPTP mice subjected to intensive treadmill exercise. Using Western immunoblotting analysis of synaptoneurosomes and __in vivo__ positron emission tomography (P

[18F]desmethoxyfallypride as a novel PET

[18F]desmethoxyfallypride as a novel PET radiotracer for quantitative in vivo dopamine D2/D3 receptor imaging in rat models of neurodegenerative diseases

✍ Máté D. Döbrössy; Friederike Braun; Stefanie Klein; Joanna Garcia; Karl-Josef La 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 392 KB

N-0923, a selective dopamine D2 receptor

N-0923, a selective dopamine D2 receptor agonist, is efficacious in rat and monkey models of Parkinson's disease

✍ Dr. J. D. Belluzzi; E. F. Domino; J. M. May; K. S. Bankiewicz; D. A. McAfee 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 800 KB

## Abstract Certain aminotetralins are known to be potent dopamine D~2~ receptor agonists. N‐0923, [‐]2‐(N‐propyl‐N‐2‐thienylethylamino)‐5‐hydroxytetralin HCl, recognizes the high and low affinity states of the D~2~ receptor in membranes from bovine caudate with a K~low~ of 79 nM. The selectivity r